239 related articles for article (PubMed ID: 24744215)
1. [Nephrolithiasis: metabolic defects and terapeutic implications].
Tasca A; Ammendola C
Urologia; 2014; 81(1):1-11. PubMed ID: 24744215
[TBL] [Abstract][Full Text] [Related]
2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
3. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
4. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
5. [Nephrolithiasis in patients with intestinal diseases].
Cirillo M; Iudici M; Marcarelli F; Laudato M; Zincone F
G Ital Nefrol; 2008; 25(1):42-8. PubMed ID: 18264917
[TBL] [Abstract][Full Text] [Related]
6. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
7. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
[TBL] [Abstract][Full Text] [Related]
8. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
[TBL] [Abstract][Full Text] [Related]
9. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
[TBL] [Abstract][Full Text] [Related]
10. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
[TBL] [Abstract][Full Text] [Related]
11. Nephrolithiasis: treatment, causes, and prevention.
Hall PM
Cleve Clin J Med; 2009 Oct; 76(10):583-91. PubMed ID: 19797458
[TBL] [Abstract][Full Text] [Related]
12. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.
Abu-Ghanem Y; Kleinmann N; Erlich T; Winkler HZ; Zilberman DE
Isr Med Assoc J; 2021 Jan; 23(1):12-16. PubMed ID: 33443336
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic hypercalciuria.
Liebman SE; Taylor JG; Bushinsky DA
Curr Rheumatol Rep; 2006 Feb; 8(1):70-5. PubMed ID: 16515769
[TBL] [Abstract][Full Text] [Related]
15. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of kidney stones.
Pak CY
Expert Opin Pharmacother; 2008 Jun; 9(9):1509-18. PubMed ID: 18518781
[TBL] [Abstract][Full Text] [Related]
17. [Renal calcium excretion and urolithiasis].
Aruga S; Honma Y
Clin Calcium; 2011 Oct; 21(10):1465-72. PubMed ID: 21960231
[TBL] [Abstract][Full Text] [Related]
18. [Use of citrate in patients with nephrolithiasis].
Marangella M
G Ital Nefrol; 2017 Aug; 34(4):51-60. PubMed ID: 28762682
[TBL] [Abstract][Full Text] [Related]
19. Update on the medical management of stone disease.
Tracy CR; Pearle MS
Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
